Lawmakers Push to Cut Breast Cancer Screening Costs

Bipartisan legislation would require insurers to cover diagnostic and supplemental breast cancer screenings without co-pays.

Updated on Nov. 19, 2026 in Cancer

Professional editorial photograph of a mammography imaging unit standing alone in a bright, clean examination room with pale blue-grey walls.
Lawmakers including Sen. Kirsten Gillibrand and Rep. Mariannette Miller-Meeks are pushing a bipartisan bill that would require insurers to cover breast cancer diagnostic and supplemental screenings without co-pays. AI Illustration. Upload story photo >

Live Poll

Would you support requiring insurers to cover breast cancer screenings without co-pays, even if premiums rise?

Sen. Kirsten Gillibrand and Rep. Mariannette Miller-Meeks pushed for passage of the Access to Breast Cancer Diagnosis Act, which would require insurance plans to cover diagnostic and supplemental breast cancer screening tests without co-pays. Lawmakers and advocates say the measure would lower the cost of breast cancer screenings in the United States.

Why it matters

Advocates say early detection is critical because symptoms often develop late, and breast cancer caught before it spreads beyond the breast has a five-year survival rate of more than 99%, according to the American Cancer Society. Advocates also acknowledge the legislation could raise insurance premiums if insurers must cover more screening procedures.

Diagnostic breast imaging is estimated by the Susan G. Komen Foundation to cost between $234 and $1,041, and 36 states have implemented assistance for these screening methods, according to the Alliance for Women's Health and Prevention. The Congressional Budget Office has not yet assessed how the legislation would affect insurance premiums.

The players

Kirsten Gillibrand

Gillibrand is a Democratic U.S. senator from New York who has championed health and women's issues in Congress.

Mariannette Miller-Meeks

Miller-Meeks is a Republican U.S. representative from Iowa who has focused on health care access and costs in her congressional work.

Susan G. Komen Foundation

The Susan G. Komen Foundation is a national breast cancer organization known for its advocacy, research funding, and patient support programs.

American Cancer Society

The American Cancer Society is a national nonprofit focused on cancer research, prevention, and patient support across the United States.

The details

The Access to Breast Cancer Diagnosis Act would require insurance plans to cover diagnostic and supplemental breast cancer screening tests without co-pays. Miller-Meeks said the legislation would work to bring diagnostic costs down.

Timeline

  1. Lawmakers said the focus should be on women's health and screening in the next Congress.

Big Picture

The bill builds on the Affordable Care Act's requirement that many preventive screenings be covered without cost-sharing, extending that logic to diagnostic and supplemental breast imaging. It would close a gap where follow-up tests can still carry significant out-of-pocket costs for patients.

If passed, the bill would let patients receive diagnostic and supplemental breast cancer screenings without co-pays under their insurance plans. Patients should still check with their insurer about covered providers and whether a given follow-up test qualifies.

The takeaway

Earlier breast cancer detection is strongly linked to survival, so knowing your insurance coverage for follow-up imaging can matter as much as the initial screening itself. Review your plan's co-pay rules before scheduling diagnostic tests.

Further reading

For related coverage, explore more Cancer news and research.

Source note: This article includes information reported by The Center Square.

Live Poll

Would you support requiring insurers to cover breast cancer screenings without co-pays, even if premiums rise?